Oracea Soolantra Association in Participants With Severe Rosacea

Completed · Phase 4 · Has a placebo group

Conditions studied: Rosacea

In brief

The main objective of this study is to evaluate the efficacy of Ivermectin 1% topical cream associated with Doxycycline 40 mg Modified release (MR) capsules versus Ivermectin 1% topical cream associated with Placebo in the treatment of severe Rosacea.

Key facts

Study ID
NCT03075891
Run by
Galderma R&D
People needed
273
Starts
2017-07-05
Expected to finish
2018-02-08
Last updated by the study team
2021-03-16

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.